<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK154653" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK154653/" /><meta name="ncbi_pagename" content="Cranioectodermal Dysplasia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Cranioectodermal Dysplasia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Cranioectodermal Dysplasia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/04/12" /><meta name="citation_author" content="Heleen Arts" /><meta name="citation_author" content="Nine Knoers" /><meta name="citation_pmid" content="24027799" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK154653/" /><meta name="citation_keywords" content="Sensenbrenner Syndrome" /><meta name="citation_keywords" content="Sensenbrenner Syndrome" /><meta name="citation_keywords" content="Intraflagellar transport protein 122 homolog" /><meta name="citation_keywords" content="Intraflagellar transport protein 43 homolog" /><meta name="citation_keywords" content="WD repeat-containing protein 19" /><meta name="citation_keywords" content="WD repeat-containing protein 35" /><meta name="citation_keywords" content="IFT122" /><meta name="citation_keywords" content="IFT43" /><meta name="citation_keywords" content="WDR19" /><meta name="citation_keywords" content="WDR35" /><meta name="citation_keywords" content="Cranioectodermal Dysplasia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Cranioectodermal Dysplasia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Heleen Arts" /><meta name="DC.Contributor" content="Nine Knoers" /><meta name="DC.Date" content="2018/04/12" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK154653/" /><meta name="description" content="Cranioectodermal dysplasia (CED), a ciliopathy also known as Sensenbrenner syndrome, is a multisystem disorder with skeletal involvement (narrow thorax, shortened proximal limbs, and brachydactyly), ectodermal features (widely-spaced hypoplastic teeth, hypodontia, sparse hair, skin laxity, abnormal nails), joint laxity, growth retardation, and characteristic facial features (frontal bossing, low-set simple ears, high forehead, telecanthus/epicanthus, full cheeks, everted lower lip). Most affected children develop nephronophthisis that often leads to end-stage renal disease (ESRD) in infancy or childhood, a major cause of morbidity and mortality. Hepatic fibrosis and retinal dystrophy, other manifestations of ciliopathies, are also observed. Dolichocephaly, often secondary to sagittal craniosynostosis, is a primary manifestation that distinguishes CED from most other ciliopathies. Brain malformations and developmental delay may also occur." /><meta name="og:title" content="Cranioectodermal Dysplasia" /><meta name="og:type" content="book" /><meta name="og:description" content="Cranioectodermal dysplasia (CED), a ciliopathy also known as Sensenbrenner syndrome, is a multisystem disorder with skeletal involvement (narrow thorax, shortened proximal limbs, and brachydactyly), ectodermal features (widely-spaced hypoplastic teeth, hypodontia, sparse hair, skin laxity, abnormal nails), joint laxity, growth retardation, and characteristic facial features (frontal bossing, low-set simple ears, high forehead, telecanthus/epicanthus, full cheeks, everted lower lip). Most affected children develop nephronophthisis that often leads to end-stage renal disease (ESRD) in infancy or childhood, a major cause of morbidity and mortality. Hepatic fibrosis and retinal dystrophy, other manifestations of ciliopathies, are also observed. Dolichocephaly, often secondary to sagittal craniosynostosis, is a primary manifestation that distinguishes CED from most other ciliopathies. Brain malformations and developmental delay may also occur." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK154653/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ce-dysp/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK154653/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AB31CDFC84B310000000003A501D0.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK154653_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK154653_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/costello/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/m-hfm-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK154653_"><span class="title" itemprop="name">Cranioectodermal Dysplasia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Sensenbrenner Syndrome</div><p class="contrib-group"><span itemprop="author">Heleen Arts</span>, PhD and <span itemprop="author">Nine Knoers</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK154653_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK154653_ai__"><div class="contrib half_rhythm"><span itemprop="author">Heleen Arts</span>, PhD<div class="affiliation small">Department of Pathology and Molecular Medicine<br />McMaster University<br />Hamilton, Ontario, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.cshh@hstra" class="oemail">ac.cshh@hstra</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nine Knoers</span>, MD, PhD<div class="affiliation small">Department of Genetics<br />University Medical Centre<br />Groningen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.gcmu@sreonk.m.a.v.v" class="oemail">ln.gcmu@sreonk.m.a.v.v</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 12, 2013</span>; Last Revision: <span itemprop="dateModified">April 12, 2018</span>.</p><p><em>Estimated reading time: 38 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ce-dysp.Summary" itemprop="description"><h2 id="_ce-dysp_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Cranioectodermal dysplasia (CED), a ciliopathy also known as Sensenbrenner syndrome, is a multisystem disorder with skeletal involvement (narrow thorax, shortened proximal limbs, and brachydactyly), ectodermal features (widely-spaced hypoplastic teeth, hypodontia, sparse hair, skin laxity, abnormal nails), joint laxity, growth retardation, and characteristic facial features (frontal bossing, low-set simple ears, high forehead, telecanthus/epicanthus, full cheeks, everted lower lip). Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children develop nephronophthisis that often leads to end-stage renal disease (ESRD) in infancy or childhood, a major cause of morbidity and mortality. Hepatic fibrosis and retinal dystrophy, other manifestations of ciliopathies, are also observed. Dolichocephaly, often secondary to sagittal craniosynostosis, is a primary manifestation that distinguishes CED from most other ciliopathies. Brain malformations and developmental delay may also occur.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CED is established in those with typical clinical findings and can be confirmed in 40% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the four genes known to be associated with CED: <i>IFT122</i> (previously <i>WDR10</i>), <i>WDR35</i> (<i>IFT121</i>), <i>WDR19</i> (<i>IFT144</i>), or <i>IFT43</i> (previously <i>C14orf179</i>).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> As needed, surgery to correct sagittal craniosynostosis (usually age &#x0003c;1 year) and/or polydactyly of the hands and feet. Routine treatment of inguinal and umbilical hernias, nephronophthisis, liver disease, and/or cardiac anomalies. For those with developmental delay: speech and physical therapy, and appropriate educational programs. For those with progressive visual impairment: low vision aids and appropriate educational programs. Human growth hormone therapy should be considered in those who meet standard treatment criteria.</p><p><i>Surveillance:</i> In infancy and childhood monitoring growth and development, and tooth development; periodic assessment of renal and liver function; annual ophthalmologic examinations starting at age four years to detect early signs of retinal degeneration.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CED is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Of the 41 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date, 23 are <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) and 18 are <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> from a total of eight families. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified. Second-trimester ultrasound examination may detect renal cysts, shortening of the limbs, and/or polydactyly.</p></div></div><div id="ce-dysp.Diagnosis"><h2 id="_ce-dysp_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria have not been established for cranioectodermal dysplasia (CED).</p><p><b>Features that should prompt consideration of CED</b> are summarized in <a class="figpopup" href="/books/NBK154653/table/ce-dysp.T.clinical_features_of_cranioect/?report=objectonly" target="object" rid-figpopup="figcedyspTclinicalfeaturesofcranioect" rid-ob="figobcedyspTclinicalfeaturesofcranioect">Table 1</a> (also see <a class="figpopup" href="/books/NBK154653/figure/ce-dysp.F1/?report=objectonly" target="object" rid-figpopup="figcedyspF1" rid-ob="figobcedyspF1">Figure 1</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcedyspF1" co-legend-rid="figlgndcedyspF1"><a href="/books/NBK154653/figure/ce-dysp.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figcedyspF1" rid-ob="figobcedyspF1"><img class="small-thumb" src="/books/NBK154653/bin/ce-dysp-Image001.gif" src-large="/books/NBK154653/bin/ce-dysp-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndcedyspF1"><h4 id="ce-dysp.F1"><a href="/books/NBK154653/figure/ce-dysp.F1/?report=objectonly" target="object" rid-ob="figobcedyspF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Various features of cranioectodermal dysplasia Patient 1 (A-E):</p></div></div><p>Although the following is arbitrary, the authors suggest that the diagnosis of CED requires at least two frequent features and two other abnormalities, including at least one ectodermal defect (i.e., involvement of the teeth, hair, or nails). Of note, dolichocephaly is a characteristic that distinguishes CED from most other ciliopathies.</p><p>Of note, the diagnosis of CED is not always easy to make, especially in a neonate in whom characteristics such as tooth defects and abnormalities of the retina, kidney, and liver are not necessarily evident. Also, craniosynostosis is not seen in every child.</p><div id="ce-dysp.T.clinical_features_of_cranioect" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Clinical Features of Cranioectodermal Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.T.clinical_features_of_cranioect/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.T.clinical_features_of_cranioect_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th><th id="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Features</th><th id="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Affected Individuals Reported in Detail (N=33)&#x000a0;<sup>1</sup></th><th id="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individuals w/a Molecularly Confirmed Diagnosis (N=15)&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Frequent (&#x0003e;75%)</b></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic facial features&#x000a0;<sup>3</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Brachydactyly&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Narrow thorax (with dysplastic ribs and pectus excavatum)&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dolichocephaly</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">28</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Shortening (and bowing) of proximal bones (mostly humeri)&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Common (50%-75%)</b></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental abnormalities (malformed, widely spaced, and/or hypodontia)&#x000a0;<sup>5</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sparse and/or thin hair&#x000a0;<sup>5</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Short stature</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Nephronophthisis</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_1" rowspan="10" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Less common (25%-50%)</b></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Joint laxity</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Liver disease (hepatic fibrosis, cirrhosis, and/or hepatomegaly)</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Syndactyly</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Abnormal nails&#x000a0;<sup>5</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Developmental delay</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Heart defect</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Skin laxity&#x000a0;<sup>5</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Recurrent lung infections</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Polydactyly</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Bilateral inguinal hernias</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Occasional to infrequent (&#x0003c;25%)</b></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Retinal dystrophy</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hip dysplasia&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td></tr><tr><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cystic hygroma</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_ce-dysp.T.clinical_features_of_cranioect_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ce-dysp.TF.1.1"><p class="no_margin">Of the 39 individuals reported to date, the 33 described in great clinical detail have been included in <a class="figpopup" href="/books/NBK154653/table/ce-dysp.T.clinical_features_of_cranioect/?report=objectonly" target="object" rid-figpopup="figcedyspTclinicalfeaturesofcranioect" rid-ob="figobcedyspTclinicalfeaturesofcranioect">Table 1</a> [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.gellis.1979.1275">Gellis et al 1979</a>, <a class="bk_pop" href="#ce-dysp.REF.young.1989.393">Young 1989</a>, <a class="bk_pop" href="#ce-dysp.REF.lang.1991.424">Lang &#x00026; Young 1991</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.lammer.1993.9">Lammer et al 1993</a>, <a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p></div></dd><dt>2. </dt><dd><div id="ce-dysp.TF.1.2"><p class="no_margin"><a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al [2006]</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al [2009]</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al [2010]</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al [2010]</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al [2011]</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al [2011]</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al [2012]</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al [2013]</a></p></div></dd><dt>3. </dt><dd><div id="ce-dysp.TF.1.3"><p class="no_margin">Facial features include frontal bossing, low-set/simple ears, high forehead, telecanthus/epicanthus, full cheeks, and everted lower lip.</p></div></dd><dt>4. </dt><dd><div id="ce-dysp.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al [1975]</a></p></div></dd><dt>5. </dt><dd><div id="ce-dysp.TF.1.5"><p class="no_margin">Ectodermal defects</p></div></dd></dl></div></div></div><p><b>The diagnosis of CED is confirmed in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the four genes &#x02013; <i>IFT122</i> (previously <i>WDR10</i>), <i>WDR35</i> (<i>IFT121</i>), <i>WDR19</i> (<i>IFT144</i>), or <i>IFT43</i> (previously <i>C14orf179</i>) &#x02013; known to cause cranioectodermal dysplasia (see <a class="figpopup" href="/books/NBK154653/table/ce-dysp.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figcedyspTmoleculargenetictestingused" rid-ob="figobcedyspTmoleculargenetictestingused">Table 2</a>). Three testing strategies are possible.</p><p><b>Strategy A</b></p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>WDR35</i> and <i>IFT122</i>, the two genes in which pathogenic variants are most likely to occur.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If no pathogenic variants are found in these two genes, perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>WDR19</i> and <i>IFT43</i>.</p></dd><dt>3.</dt><dd><p class="no_top_margin">If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>* of <i>WDR35</i> may be considered; however, to date such <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>/multiexon rearrangements have not been reported as a cause of CED.</p><p> *Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA; included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></dd></dl><p><b>Strategy B.</b> In children with multiple defects for whom a clear diagnosis is lacking, perform <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> microarray analysis, which may reveal <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> regions that contain ciliary genes that can subsequently be targeted for <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Strategy C.</b> Use ciliopathy multigene panels that include the genes of interest. For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="ce-dysp.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Cranioectodermal Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup> /<br />Locus Name</th><th id="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of CED Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th><th id="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IFT122</i> / CED 1</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/41</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR35</i> / CED 2</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">9/41</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown; no deletions/duplications reported&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IFT43</i> / CED 3</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/41</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR19</i> / CED 4</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/41</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23/41</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_ce-dysp.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ce-dysp.TF.2.1"><p class="no_margin">See <a href="/books/NBK154653/#ce-dysp.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ce-dysp.TF.2.2"><p class="no_margin">Based on literature reports describing individuals with molecularly confirmed and unconfirmed CED</p></div></dd><dt>3. </dt><dd><div id="ce-dysp.TF.2.3"><p class="no_margin">See <a href="#ce-dysp.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>4. </dt><dd><div id="ce-dysp.TF.2.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="ce-dysp.TF.2.5"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA; included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>6. </dt><dd><div id="ce-dysp.TF.2.6"><p class="no_margin">No deletions or duplications involving <i>WDR35</i> have been reported to cause cranioectodermal dysplasia 2. See also <a href="#ce-dysp.Genetically_Related_Allelic_Diso">Genetically Related Disorders</a> for a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> resulting from <i>WDR35</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</p></div></dd><dt>7. </dt><dd><div id="ce-dysp.TF.2.7"><p class="no_margin">It is likely that variants in genes other than the four known genes also cause CED, given that the genetic defect has yet to be identified in 60% of persons with CED [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]. However, it is unclear from reports in the literature whether all four known genes were tested in all reported individuals. If the cause of CED is indeed more heterogeneous than presently known, it is reasonable to expect that variants in genes that (directly or indirectly) regulate intraflagellar transport and/or are mutated in other ciliopathies similar to CED are causative.</p></div></dd></dl></div></div></div></div><div id="ce-dysp.Clinical_Characteristics"><h2 id="_ce-dysp_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ce-dysp.Clinical_Description"><h3>Clinical Description</h3><p>Cranioectodermal dysplasia (CED), one of the ciliopathies, is a multisystem disorder with significant involvement of the skeleton, ectoderm (teeth, hair, and nails), retina, kidneys, liver and lungs, and occasionally the brain. The current understanding of the CED <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is limited by the small number of well-described <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported and the even smaller number with a molecularly confirmed diagnosis.</p><p>Of the 41 individuals reported to date, 23 are <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) and 18 are <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases. Of the 41, 31 have been described in great clinical detail [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.gellis.1979.1275">Gellis et al 1979</a>, <a class="bk_pop" href="#ce-dysp.REF.young.1989.393">Young 1989</a>, <a class="bk_pop" href="#ce-dysp.REF.lang.1991.424">Lang &#x00026; Young 1991</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.lammer.1993.9">Lammer et al 1993</a>, <a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p><p>In 16, the molecular basis of CED (<a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>IFT122, WDR35, IFT43,</i> or <i>WDR19</i>) has been identified [<a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p><p>The following discussion focuses on a combination of individuals with or without a molecularly confirmed diagnosis.</p><p><b>Dolichocephaly</b> (apparently increased antero-posterior length of the head compared to width) and frontal bossing are usually secondary to sagittal craniosynostosis, which is usually present at birth. Sib pairs may show discordance for sagittal craniosynostosis [<a class="bk_pop" href="#ce-dysp.REF.lang.1991.424">Lang &#x00026; Young 1991</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>].</p><p><b>Characteristic facial features</b> that can be observed from birth are evident in practically all individuals with CED (<a class="figpopup" href="/books/NBK154653/figure/ce-dysp.F1/?report=objectonly" target="object" rid-figpopup="figcedyspF1" rid-ob="figobcedyspF1">Figure 1</a>).</p><p>Features often seen:</p><ul><li class="half_rhythm"><div>Frontal bossing, bitemporal narrowing, and a tall forehead [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]</div></li><li class="half_rhythm"><div>Low-set, simple and/or posteriorly rotated ears [<a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]</div></li><li class="half_rhythm"><div>Telecanthus, epicanthal folds, and/or down/upslanting palpebral fissures [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.lammer.1993.9">Lammer et al 1993</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]</div></li><li class="half_rhythm"><div>Full cheeks [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]</div></li><li class="half_rhythm"><div>Micrognathia [<a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]</div></li><li class="half_rhythm"><div>Everted lower lip [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>]</div></li><li class="half_rhythm"><div>Anteverted nares [<a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]</div></li></ul><p><b>Skeletal findings</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Hands and feet.</b> Prenatal echography may detect polydactyly during mid-gestation; however, brachydactyly is not discernible earlier in development [<a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>]. Neonates often have: brachydactyly (middle and distal phalanges often short and/or abnormally shaped) [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]; post-axial polydactyly [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>]; and cutaneous syndactyly of fingers and toes (most frequently mild cutaneous syndactyly of toes 2 and 3) [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.gellis.1979.1275">Gellis et al 1979</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div><div class="half_rhythm">Epiphyses of phalanges can have a normal appearance on x-ray or can be flattened or cone shaped [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>].</div><div class="half_rhythm">Other findings of the hands and feet variably seen:</div><ul><li class="half_rhythm"><div>Fifth finger clinodactyly [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>]</div></li><li class="half_rhythm"><div>Abnormal palmar creases [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]</div></li><li class="half_rhythm"><div>Restricted finger flexion [<a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>]</div></li><li class="half_rhythm"><div>Osteoporosis [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>]</div></li><li class="half_rhythm"><div>Sandal gap [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>]</div></li><li class="half_rhythm"><div>Triphalangeal hallux [<a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>]</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>A narrow thorax with short dysplastic ribs</b> may be noted as early as mid-gestation; however, this finding was most commonly first noted at birth [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.lang.1991.424">Lang &#x00026; Young 1991</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Pectus excavatum</b> is often observed [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Rib deformities</b> (e.g., short ribs or coat-hanger-shaped ribs) may normalize during childhood [<a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Shortening (and bowing) of proximal long bones</b> has been noted as early as 23 weeks' gestation [<a class="bk_pop" href="#ce-dysp.REF.lang.1991.424">Lang &#x00026; Young 1991</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div><div class="half_rhythm">Upper limbs are often shorter compared to lower limbs; humeri are particularly affected [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.young.1989.393">Young 1989</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div><div class="half_rhythm">Long bones may display bowing, and epiphyses may be flattened and/or display metaphyseal flaring [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Growth retardation</b> is commonly reported in CED (<a class="figpopup" href="/books/NBK154653/table/ce-dysp.T.clinical_features_of_cranioect/?report=objectonly" target="object" rid-figpopup="figcedyspTclinicalfeaturesofcranioect" rid-ob="figobcedyspTclinicalfeaturesofcranioect">Table 1</a>). At birth the length as related to gestational age may be within the normal range, but can also be below the third centile [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>].</div><div class="half_rhythm">Infants may have a retarded growth with length below the third centile, but growth retardation may also be milder (length between the 5th and 10th centile) [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div><div class="half_rhythm">In 11 of 31 children with CED ranging in age from three to 11 years, height was specifically reported to be below the third centile [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div></li></ul><p><b>Ectodermal defects</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Teeth.</b> Tooth eruption is often delayed [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>].</div><ul><li class="half_rhythm"><div>Deciduous teeth are generally small and widely spaced. Hypodontia, enamel defects, taurodontia, and fused and cone-shaped teeth have also been reported [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>].</div></li><li class="half_rhythm"><div>Similar characteristics are seen in permanent teeth. Hypo- or oligodontia may affect upper as well as lower permanent teeth [<a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Skin.</b> Prenatal echography may reveal mid-gestational nuchal webbing and skin thickening [<a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div><div class="half_rhythm">Generalized skin laxity and redundant skin folds have been reported in infancy and thereafter. Skin folds have been found particularly at the neck, ankles, and wrists. Skin may be dry; hyperkeratosis has been reported [<a class="bk_pop" href="#ce-dysp.REF.lammer.1993.9">Lammer et al 1993</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hair.</b> Most infants and young children with CED have sparse, fine hair. Hair may be hypopigmented with reduced diameter. Hair growth may also be affected [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.lammer.1993.9">Lammer et al 1993</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</div><div class="half_rhythm">In some instances hair growth may normalize during childhood as suggested by <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al [2009]</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Nails</b> are short, broad, and slow-growing from infancy [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.lang.1991.424">Lang &#x00026; Young 1991</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</div></li></ul><p><b>Kidney</b> involvement is nephronophthisis (tubulointerstitial nephritis). At least 60% (21/33) of persons with CED were reported to have renal insufficiency.</p><p>Although end-stage renal disease (ESRD) can be evident prenatally as poly/oligohydramnios and small cystic kidneys in the second trimester of pregnancy, the first signs of renal disease are often evident in early childhood (age ~2 years) [<a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</p><p>Initially reduced urinary concentrating ability leads to polyuria and polydipsia. Nocturnal enuresis may be evident. Hypertension, proteinuria, hematuria, and electrolyte imbalances usually develop later in the disease course as a result of renal insufficiency and filtration defects.</p><p>In ten of 21 children renal disease progressed to ESRD. Of note, this number may have increased over time as follow-up studies are limited. Most children developed ESRD between ages two and six years [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p><p>Renal ultrasound examination in infancy and early childhood usually shows normal-sized or small kidneys with increased echogenicity and poor corticomedullary differentiation [<a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p><p>Renal biopsy shows interstitial fibrosis with focal inflammatory cell infiltrates, tubular atrophy, glomerulosclerosis, and occasional cysts [<a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]. The latter features occur in advanced disease.</p><p><b>Liver</b> findings range from hepatosplenomegaly without signs of progressive liver disease to extensive liver abnormalities including (recurrent) hyperbilirubinemia and cholestatic disease requiring hospitalization in the newborn period [<a class="bk_pop" href="#ce-dysp.REF.young.1989.393">Young 1989</a>, <a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</p><p>Hyperbilirubinemia, liver cirrhosis, severe cholestasis with bile duct proliferation, and acute cholangitis have been described in infants [<a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p><p>Longitudinal data on liver disease are not available; however, the long-term prognosis with respect to liver fibrosis and cirrhosis is probably poor.</p><p>Liver cysts have been detected in children age three and four years [<a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>], but also as early as age ten months [<a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p><p><b>Eye</b> findings include retinal dystrophy and nystagmus [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]. Nyctalopia (night blindness) is often evident in the first years of life [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>].</p><p>Abnormal scotopic and photopic electroretinograms (ERGs) have been reported as early as ages four to 11 years, while fundoscopy has revealed attenuated arteries and bone-spicule-shaped deposits as early as ages five to 11 years in some [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>].</p><p>The natural history of the retinal dystrophy remains to be reported; however, in overlapping ciliopathies such as Bardet-Biedl syndrome, night blindness usually progresses to legal blindness in young adults (see <a href="/books/n/gene/bbs/">Bardet-Biedl Syndrome</a>). A similar prognosis is to be expected in CED.</p><p>Other ophthalmologic findings include:</p><ul><li class="half_rhythm"><div>Nystagmus [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>];</div></li><li class="half_rhythm"><div>Hyperopia [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>];</div></li><li class="half_rhythm"><div>Myopia [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>];</div></li><li class="half_rhythm"><div>Esotropia [<a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>];</div></li><li class="half_rhythm"><div>Myopic/hypermetropic astigmatism [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>];</div></li><li class="half_rhythm"><div>Euryblepharon (excess horizontal eyelid length) [<a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>].</div></li></ul><p><b>Pulmonary.</b> In infancy or early childhood, children with CED may experience life-threatening respiratory distress and recurrent respiratory infections. Asthma and pneumothorax have also been reported [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</p><p>Many children die of respiratory distress after birth or of pneumonia during early childhood [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>].</p><p>Recurrent respiratory infections have been reported to become less frequent with time [<a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>].</p><p><b>Cardiac malformations</b> have included patent ductus arteriosus and atrial and ventricular septal defects. Thickening of the mitral and tricuspid valves, ventricular hypertrophy/dilation, and peripheral pulmonary stenosis have also been reported [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</p><p><a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al [2012]</a> reported that at age three years cardiac arrhythmia and atrial septal defect resolved in one child with CED.</p><p><b>Central nervous system.</b> Although the majority of children develop normally, milestones may be (mildly) delayed in a subset [<a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</p><p>Sitting unsupported may be delayed to nine to 15 months, and walking to three years [<a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</p><p>Delays in speech may vary from a few words at age 19 months to no words at age five years [<a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>]. No information is available on how <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals respond to speech and physical therapy.</p><p>Cognitive and social abilities are usually normal [<a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>].</p><p>Brain imaging has revealed the following abnormalities:</p><ul><li class="half_rhythm"><div>Cortical atrophy [<a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>]</div></li><li class="half_rhythm"><div>Ventriculomegaly [<a class="bk_pop" href="#ce-dysp.REF.lammer.1993.9">Lammer et al 1993</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]</div></li><li class="half_rhythm"><div>Large cisterna magna [<a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>]</div></li><li class="half_rhythm"><div>Hypoplasia of the corpus callosum [<a class="bk_pop" href="#ce-dysp.REF.lammer.1993.9">Lammer et al 1993</a>, <a class="bk_pop" href="#ce-dysp.REF.zannolli.2001.332">Zannolli et al 2001</a>]</div></li><li class="half_rhythm"><div>Focal microdysgenesis [<a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>]</div></li><li class="half_rhythm"><div>Enlarged extracerebral fluid spaces [<a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>]</div></li><li class="half_rhythm"><div>A large posterior fossa cyst [<a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>]</div></li></ul><p><b>Other</b></p><ul><li class="half_rhythm"><div>Joint laxity can be observed from the neonatal period [<a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>].</div></li><li class="half_rhythm"><div>(Bilateral) inguinal hernias and/or umbilical hernia can present in neonates or during the first year of life [<a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>].</div></li></ul><p><b>Life expectancy.</b> Morbidity is high in CED and hospitalization may be frequent and/or long-term [<a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.obikane.2006.574">Obikane et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</p><p>Mortality rates are unclear, although 7/33 of children with CED died before age seven years of respiratory failure [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.tamai.2002.78">Tamai et al 2002</a>], heart failure [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>], hypovolemic shock (as a result of coagulopathy) [<a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>], or unknown causes [<a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]. This number could be higher as longitudinal data on the majority of individuals with CED are unavailable.</p><p>At least two persons with CED survived into young adulthood. See <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al [2011]</a> and <a class="figpopup" href="/books/NBK154653/figure/ce-dysp.F1/?report=objectonly" target="object" rid-figpopup="figcedyspF1" rid-ob="figobcedyspF1">Figure 1</a>.</p></div><div id="ce-dysp.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Clinical manifestations of cranioectodermal dysplasia are highly variable and may differ between and within families [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</p><p>Phenotypes resulting from <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in any one of the four known genes (i.e., <i>IFT122</i>, <i>WDR35</i>, <i>IFT43</i>, or <i>WDR19)</i> are not distinguishable [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</p><p>Reports published to date involve too few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to draw reliable insights into <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>. Although future studies are needed to determine whether true genotype-phenotype correlations exist in CED, it appears that (based on current limited data) some clinical findings could be associated with pathogenic variants in specific genes:</p><ul><li class="half_rhythm"><div>Retinal dystrophy has only been reported in one family with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>WDR19</i> pathogenic variants [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>].</div></li><li class="half_rhythm"><div><i>WDR35</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with developmental delay, albeit not in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</div></li><li class="half_rhythm"><div>Renal insufficiency often develops in infancy or early childhood in children with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>IFT122</i>, <i>WDR35</i>, <i>IFT43</i>, or <i>WDR19</i>; however, two children with biallelic <i>WDR35</i> pathogenic variants were said to be free of renal disease at ages seven and nine years [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>].</div></li></ul><p>Note: None of the pathogenic variants in <i>IFT122</i>, <i>WDR35</i>, <i>IFT43</i>, and <i>WDR19</i> are <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, or other <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants; such variants would most likely result in early embryonic lethality. Similarly, biallelic null variants are not observed in the clinically and genetically overlapping short rib-polydactyly syndromes (see <a href="#ce-dysp.Differential_Diagnosis">Differential Diagnosis</a>) presumably because of early embryonic lethality.</p></div><div id="ce-dysp.Penetrance"><h3>Penetrance</h3><p>Most individuals with molecularly confirmed CED have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that affect highly conserved nucleotides or a combination of a pathogenic missense variant with a severe, truncating variant; in these cases <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of cranioectodermal dysplasia is 100%.</p></div><div id="ce-dysp.Nomenclature"><h3>Nomenclature</h3><p>Cranioectodermal dysplasia (CED) was first described as Sensenbrenner syndrome in a sib pair with dolichocephaly, rhizomelic shortening of the bones, brachydactyly, and ectodermal defects [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>]. Subsequently <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al [1977]</a> described <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from two additional families and renamed the disorder cranioectodermal dysplasia.</p><p>Over time it was recognized that the skeletal and ectodermal features of cranioectodermal dysplasia are often accompanied by anomalies of visceral organs including the kidney, liver, and heart [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.amar.1997.349">Amar et al 1997</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>].</p></div><div id="ce-dysp.Prevalence"><h3>Prevalence</h3><p>Cranioectodermal dysplasia is rare; its exact frequency is unknown. Fewer than 60 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported. In the Dutch population of 17 million people only five families (6 affected individuals) with CED are known to the authors.</p></div></div><div id="ce-dysp.Genetically_Related_Allelic_Diso"><h2 id="_ce-dysp_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>IFT122</i> or <i>IFT43</i>.</p><p><b><i>WDR35</i></b></p><ul><li class="half_rhythm"><div>An <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <i>WDR35</i> <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> 2,847-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> spanning <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5 was identified in a family with short rib-polydactyly syndrome type V [<a class="bk_pop" href="#ce-dysp.REF.mill.2011.508">Mill et al 2011</a>].</div></li><li class="half_rhythm"><div>Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> changes (p.Arg545Ter and p.Trp261Arg) were identified in another family with short rib-polydactyly syndrome type V [<a class="bk_pop" href="#ce-dysp.REF.mill.2011.508">Mill et al 2011</a>].</div></li></ul><p><b><i>WDR19.</i></b> Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants (p.Val345Gly and p.Tyr1023Ter) were reported in a family with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> nephronophthisis, and a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (p.Leu7Pro) was found in a family with Jeune asphyxiating thoracic dystrophy [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]. See <a href="/books/n/gene/nephron-ov/">Nephronophthisis</a>.</p><p>More recently, <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants were also detected in two families with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> retinal dystrophy (p.Leu710Ser and p.Asp493His), three families with Senior-L&#x000f8;ken syndrome (p.Leu214PhefsTer5, p.Asp493His, p.Val68Asp, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant c.407-2A&#x0003e;G) [<a class="bk_pop" href="#ce-dysp.REF.coussa.2013.150">Coussa et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.halbritter.2013.865">Halbritter et al 2013</a>], and three families with Caroli disease with or without additional features (p.Gln228Ter, p.Glu1235Lys, and p.Arg1178Gln) [<a class="bk_pop" href="#ce-dysp.REF.halbritter.2013.865">Halbritter et al 2013</a>]. (See <a href="#ce-dysp.Differential_Diagnosis">Differential Diagnosis</a>.)</p></div><div id="ce-dysp.Differential_Diagnosis"><h2 id="_ce-dysp_Differential_Diagnosis_">Differential Diagnosis</h2><p>Cranioectodermal dysplasia (CED) is part of a spectrum of disorders caused by disruption of the cilium, an organelle of the cell that appears and functions as an antenna (<a class="figpopup" href="/books/NBK154653/figure/ce-dysp.F2/?report=objectonly" target="object" rid-figpopup="figcedyspF2" rid-ob="figobcedyspF2">Figure 2</a>) [<a class="bk_pop" href="#ce-dysp.REF.huber.2012.165">Huber &#x00026; Cormier-Daire 2012</a>]. These disorders, collectively referred to as ciliopathies, display marked phenotypic overlap. Typical clinical features of ciliopathies are renal cystic disease, retinal dystrophy, shortening of ribs, phalanges and long bones, polydactyly, hepatic fibrosis, and developmental delay.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcedyspF2" co-legend-rid="figlgndcedyspF2"><a href="/books/NBK154653/figure/ce-dysp.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figcedyspF2" rid-ob="figobcedyspF2"><img class="small-thumb" src="/books/NBK154653/bin/ce-dysp-Image002.gif" src-large="/books/NBK154653/bin/ce-dysp-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndcedyspF2"><h4 id="ce-dysp.F2"><a href="/books/NBK154653/figure/ce-dysp.F2/?report=objectonly" target="object" rid-ob="figobcedyspF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Schematic architecture of a cilium and ciliary transport The cilium is a tail-like protrusion from the apical plasma membrane of the cell. It is composed of two compartments: the basal body from which the cilium is initially assembled, and the ciliary <a href="/books/NBK154653/figure/ce-dysp.F2/?report=objectonly" target="object" rid-ob="figobcedyspF2">(more...)</a></p></div></div><p>Within the ciliopathies, Jeune asphyxiating thoracic dystrophy, Mainzer-Saldino syndrome, Ellis-van Creveld syndrome, and the short rib-polydactyly syndromes resemble cranioectodermal dysplasia the most. Each is described in more detail below.</p><p>Other ciliopathies that clinically overlap with cranioectodermal dysplasia include <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> <a href="/books/n/gene/nephron-ov/">nephronophthisis</a>, isolated retinal dystrophy, Caroli disease, Senior-L&#x000f8;ken syndrome, <a href="/books/n/gene/joubert/">Joubert syndrome</a>, Meckel-Gruber syndrome, and <a href="/books/n/gene/bbs/">Bardet-Biedl syndrome</a> [<a class="bk_pop" href="#ce-dysp.REF.huber.2012.165">Huber &#x00026; Cormier-Daire 2012</a>].</p><p><b>Jeune asphyxiating thoracic dystrophy (JATD)</b> (OMIM <a href="http://omim.org/entry/208500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">208500</a>) has a strong phenotypic overlap with CED [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>, <a class="bk_pop" href="#ce-dysp.REF.savill.1997.215">Savill et al 1997</a>]. Skeletal abnormalities that occur in both disorders are polydactyly, brachydactyly, and rhizomelic limb shortening. Extraskeletal features that may be present in both include renal cystic disease, liver anomalies, and/or retinal dystrophy.</p><p>Both CED and JATD are characterized by a narrow rib cage <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; however, the phenotype is usually mild in CED and more pronounced in JATD, often leading to severe respiratory distress; in a review of ten newborns or infants with JATD, six died of respiratory insufficiency [<a class="bk_pop" href="#ce-dysp.REF.oberklaid.1977.758">Oberklaid et al 1977</a>].</p><p>The main difference between CED and JATD is that JATD lacks the ectodermal changes and craniosynostosis characteristic of CED [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>].</p><p>JATD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. It can be caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>IFT80</i> [<a class="bk_pop" href="#ce-dysp.REF.beales.2007.727">Beales et al 2007</a>], <i>DYNC2H1</i> [<a class="bk_pop" href="#ce-dysp.REF.dagoneau.2009.706">Dagoneau et al 2009</a>], <i>TTC21B</i> [<a class="bk_pop" href="#ce-dysp.REF.davis.2011.189">Davis et al 2011</a>], <i>IFT140</i> [<a class="bk_pop" href="#ce-dysp.REF.perrault.2012.864">Perrault et al 2012</a>], or <i>WDR19</i> [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]. Of note, pathogenic variants in <i>WDR19</i> have been reported in both JATD and CED [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>].</p><p><b>Mainzer-Saldino syndrome (MZSDS)</b> (OMIM <a href="http://omim.org/entry/266920" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">266920</a>) is mainly characterized by phalangeal cone-shaped epiphyses, retinal dystrophy, and nephronophthisis [<a class="bk_pop" href="#ce-dysp.REF.mainzer.1970.556">Mainzer et al 1970</a>, <a class="bk_pop" href="#ce-dysp.REF.perrault.2012.864">Perrault et al 2012</a>]. Cerebellar ataxia, a narrow thorax, scaphocephaly, and hepatic fibrosis are variably present [<a class="bk_pop" href="#ce-dysp.REF.perrault.2012.864">Perrault et al 2012</a>].</p><p>MZSDS usually lacks the typical ectodermal features of CED [<a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>].</p><p>MZSDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Biallelic pathogenic variants in <i>IFT140</i> have been identified in both MZSDS and JATD [<a class="bk_pop" href="#ce-dysp.REF.perrault.2012.864">Perrault et al 2012</a>].</p><p><b>Ellis-van Creveld (EVC) syndrome</b> (OMIM <a href="http://omim.org/entry/225500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">225500</a>), first described by <a class="bk_pop" href="#ce-dysp.REF.ellis.1940.65">Ellis &#x00026; van Creveld [1940]</a>, is a skeletal dysplasia characterized by postaxial polydactyly, shortening of the limbs and ribs, and ectodermal dysplasia affecting hair, nails, and teeth [<a class="bk_pop" href="#ce-dysp.REF.ruizperez.2000.283">Ruiz-Perez et al 2000</a>, <a class="bk_pop" href="#ce-dysp.REF.huber.2012.165">Huber &#x00026; Cormier-Daire 2012</a>]. EVC syndrome was considered in the differential diagnosis of CED several decades ago [<a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.young.1989.393">Young 1989</a>, <a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>].</p><p>Congenital heart disease is also a major finding in EVC syndrome; septal defects (mainly atrial) occur in 60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#ce-dysp.REF.ruizperez.2000.283">Ruiz-Perez et al 2000</a>, <a class="bk_pop" href="#ce-dysp.REF.baujat.2007.27">Baujat &#x00026; Le Merrer 2007</a>]. The frequency of heart defects in EVC syndrome is greater than in CED (as indicated in <a class="figpopup" href="/books/NBK154653/table/ce-dysp.T.clinical_features_of_cranioect/?report=objectonly" target="object" rid-figpopup="figcedyspTclinicalfeaturesofcranioect" rid-ob="figobcedyspTclinicalfeaturesofcranioect">Table 1</a>).</p><p>EVC syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Biallelic pathogenic variants in one of two genes positioned head-to-head on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 4, <i>EVC</i> and <i>EVC2</i>, have been identified in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#ce-dysp.REF.ruizperez.2000.283">Ruiz-Perez et al 2000</a>, <a class="bk_pop" href="#ce-dysp.REF.ruizperez.2003.728">Ruiz-Perez et al 2003</a>].</p><p><b>Short rib-polydactyly syndromes (SRPS),</b> five disorders that are lethal in the perinatal period due to a severe narrow rib cage <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, are generally characterized by extremely short ribs and limbs, polydactyly, and malformations in a variety of organs [<a class="bk_pop" href="#ce-dysp.REF.el_ioglu.2002.392">El&#x000e7;ioglu &#x00026; Hall 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.huber.2012.165">Huber &#x00026; Cormier-Daire 2012</a>]. The five short rib-polydactyly syndromes are not always clinically distinguishable: phenotypic and genetic overlap has been reported [<a class="bk_pop" href="#ce-dysp.REF.el_ioglu.2002.392">El&#x000e7;ioglu &#x00026; Hall 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.el_hokayem.2012.227">El Hokayem et al 2012</a>].</p><p>The five short rib-polydactyly syndromes are:</p><ul><li class="half_rhythm"><div>SRPS I: Saldino-Noonan syndrome (OMIM <a href="http://omim.org/entry/263530" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">263530</a>)</div></li><li class="half_rhythm"><div>SRPS II: Majewski syndrome (OMIM <a href="http://omim.org/entry/263520" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">263520</a>)</div></li><li class="half_rhythm"><div>SRPS III: Verma-Naumoff syndrome (OMIM <a href="http://omim.org/entry/263510" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">263510</a>)</div></li><li class="half_rhythm"><div>SRPS IV: Beemer Langer syndrome (OMIM <a href="http://omim.org/entry/269860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">269860</a>)</div></li><li class="half_rhythm"><div>SRPS V: (OMIM <a href="http://omim.org/entry/614091" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614091</a>) [<a class="bk_pop" href="#ce-dysp.REF.el_ioglu.2002.392">El&#x000e7;ioglu &#x00026; Hall 2002</a>, <a class="bk_pop" href="#ce-dysp.REF.mill.2011.508">Mill et al 2011</a>]. SRPS V is caused by pathogenic variants in <i>WDR35</i> [<a class="bk_pop" href="#ce-dysp.REF.mill.2011.508">Mill et al 2011</a>], which is also mutated in individuals with CED [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>]. See <a href="#ce-dysp.Genetically_Related_Allelic_Diso">Genetically Related Disorders</a>.</div></li></ul><p><b>Senior-L&#x000f8;ken syndrome</b> (OMIM <a href="http://omim.org/entry/266900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">266900</a>) is a heterogeneous <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder that is characterized by nephronophthisis and retinal dystrophy. Pathogenic variants in various genes have been detected in persons with Senior-L&#x000f8;ken syndrome, including <i>WDR19</i>, which is also mutated in CED [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2013.863">Arts &#x00026; Knoers 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.coussa.2013.150">Coussa et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.halbritter.2013.865">Halbritter et al 2013</a>].</p><p><b>Caroli disease</b> (OMIM <a href="http://omim.org/entry/600643" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600643</a>) is characterized by polycystic liver disease and cholangitis. It is part of the <a href="/books/n/gene/pkd-ar/">autosomal recessive polycystic kidney disease</a> (ARPKD) spectrum of disorders and can occur as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding as well as in combination with other features including renal cystic disease [<a class="bk_pop" href="#ce-dysp.REF.adeva.2006.1">Adeva et al 2006</a>].</p><p><b>Autosomal recessive retinal dystrophy</b> (also known as <a href="/books/n/gene/rp-overview/">retinitis pigmentosa</a>) can be an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding or occur in <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> disorders such as CED [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]. Retinitis pigmentosa usually starts with night blindness and can progress to complete blindness later in life due to loss of the photoreceptors (rods and cones). The fundus often displays attenuation of retinal vessels and may reveal abnormal peripheral pigmentation (referred to as bone-spicule deposits) [<a class="bk_pop" href="#ce-dysp.REF.hartong.2006.1795">Hartong et al 2006</a>]. Over 50% of families with isolated retinitis pigmentosa have an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form. Pathogenic variants in more than 30 genes can cause RP, and almost two thirds of these genes encode ciliary proteins [<a class="bk_pop" href="#ce-dysp.REF.hartong.2006.1795">Hartong et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.estradacuzcano.2012.r111">Estrada-Cuzcano et al 2012</a>].</p><p><b>EEM syndrome</b> (<i>e</i>ctodermal dysplasia, <i>e</i>ctrodactyly [split hand-split foot malformation], and progressive <i>m</i>acular dystrophy) is a rare disorder that is clinically related to CED [<a class="bk_pop" href="#ce-dysp.REF.ohdo.1983.52">Ohdo et al 1983</a>, <a class="bk_pop" href="#ce-dysp.REF.eke.1996.490">Eke et al 1996</a>]. EEM syndrome can be distinguished from CED as split hand-split foot malformation does not occur in CED. Biallelic pathogenic variants in <i>CDH3</i> [<a class="bk_pop" href="#ce-dysp.REF.kjaer.2005.292">Kjaer et al 2005</a>] are causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p></div><div id="ce-dysp.Management"><h2 id="_ce-dysp_Management_">Management</h2><div id="ce-dysp.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of a newborn or infant diagnosed with cranioectodermal dysplasia (CED), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>CT scan to determine if sagittal synostosis is the cause of dolichocephaly</div></li><li class="half_rhythm"><div>X-ray of thorax and long bones to determine the extent of skeletal findings</div></li><li class="half_rhythm"><div>Examination of the skin, hair, nails, and teeth</div></li><li class="half_rhythm"><div>Renal ultrasound examination and urine measurements (including a urine collection test [and an optional DDAVP test] to assay polyuria, and osmolarity sampling of morning urine to determine concentrating ability). A biopsy is often taken after detection of abnormalities.</div></li><li class="half_rhythm"><div>Liver ultrasound examination and measurement of liver enzymes</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Evaluation by a pulmonologist</div></li><li class="half_rhythm"><div>Cardiac evaluation for detection of possible structural heart defects</div></li><li class="half_rhythm"><div>Developmental evaluation</div></li><li class="half_rhythm"><div>Brain MRI in individuals with developmental delay to assess the cause of the delay</div></li><li class="half_rhythm"><div>Clinical genetics consultation</div></li></ul></div><div id="ce-dysp.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment includes the following:</p><ul><li class="half_rhythm"><div>Surgery for correcting craniosynostosis (usually in first year of life) [<a class="bk_pop" href="#ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner et al 1975</a>, <a class="bk_pop" href="#ce-dysp.REF.levin.1977.55">Levin et al 1977</a>, <a class="bk_pop" href="#ce-dysp.REF.genitori.1992.601">Genitori et al 1992</a>, <a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>].</div></li><li class="half_rhythm"><div>Correction of polydactyly (optional)</div></li><li class="half_rhythm"><div>Orthopedic care as required (e.g., for hip dysplasia)</div></li><li class="half_rhythm"><div>Growth hormone treatment to stimulate growth when standard criteria for this treatment are met [<a class="bk_pop" href="#ce-dysp.REF.wilson.2003.415">Wilson et al 2003</a>]. Growth hormone should only be prescribed to children with severe growth retardation in whom the therapy is expected to be successful.</div></li><li class="half_rhythm"><div>Dental care. Timely detection and intervention of structural tooth abnormalities and/or oligodontia may limit aesthetic, functional, and psychological issues.</div></li><li class="half_rhythm"><div>Standard treatment for renal and liver abnormalities. While liver transplantation is a treatment option in advanced stages, it has only been proposed once for an individual with CED [<a class="bk_pop" href="#ce-dysp.REF.zaffanello.2006.2336">Zaffanello et al 2006</a>].</div></li><li class="half_rhythm"><div>For those with progressive visual impairment, low vision aids and appropriate educational programs</div></li><li class="half_rhythm"><div>Mechanical ventilation as required in newborns to treat respiratory insufficiency due to pulmonary hypoplasia. Pneumonia should be treated with antibiotics. Patients susceptible to recurrent respiratory infections should be treated with long-term prophylaxis. Asthma can be treated with steroids.</div></li><li class="half_rhythm"><div>Standard treatment for cardiac abnormalities</div></li><li class="half_rhythm"><div>For those with developmental delay, speech therapy and physical therapy to improve motor skills and appropriate educational programs</div></li><li class="half_rhythm"><div>Surgical intervention as required for inguinal/umbilical hernias [<a class="bk_pop" href="#ce-dysp.REF.fry.2009.2212">Fry et al 2009</a>]</div></li></ul></div><div id="ce-dysp.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Monitoring growth and development during infancy and childhood starting at the time of diagnosis</div></li><li class="half_rhythm"><div>Beginning at age one year, examination of teeth with regular follow-up to detect tooth damage and oligodontia</div></li><li class="half_rhythm"><div>Periodic monitoring starting at the time of diagnosis for signs of nephronophthisis (renal insufficiency, renal cyst formation), including osmolarity testing in morning urine, urine collection assays to test for polyuria, measurement of blood pressure, determination of serum creatinine and blood urea concentrations to establish renal function, and periodic renal ultrasound examination to establish kidney size and presence of cysts. Periodic measurement of liver enzymes starting at the time of diagnosis.</div></li><li class="half_rhythm"><div>Annual ophthalmologic examinations starting at age four years. Note: Electroretinography (ERG) and fundoscopy can be performed at an earlier age if it is evident that vision is reduced.</div></li><li class="half_rhythm"><div>Evaluation for respiratory infection (with x-rays and sputum analysis) when clinical findings suggest pneumonia</div></li><li class="half_rhythm"><div>In those with structural heart defects, periodic monitoring of cardiac function including auscultation, ECG, and echocardiography</div></li></ul></div><div id="ce-dysp.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>If the pathogenic variants are known in a family, it is appropriate to clarify the genetic status of at-risk infants to allow early diagnosis and appropriate management and surveillance, particularly for respiratory complications, renal and liver disease, and visual impairment.</p><p>If the pathogenic variants are not known in a family, the following is recommended for at-risk children:</p><ul><li class="half_rhythm"><div>In the newborn period: physical examination by a pediatrician, and consultation with a clinical geneticist as determined by the clinical findings</div></li><li class="half_rhythm"><div>Age 0-3 months: kidney and liver evaluation, including ultrasound examination and measurement of blood pressure, serum creatinine concentration, and liver enzymes</div></li><li class="half_rhythm"><div>At six-month intervals: repeat the kidney and liver evaluations.</div></li></ul><p>Parents should be alerted to the signs of CED and advised to contact their child's health care provider if suspicious symptoms, such as polydipsia and/or jaundice, appear.</p><p>See <a href="#ce-dysp.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ce-dysp.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ce-dysp.Genetic_Counseling"><h2 id="_ce-dysp_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ce-dysp.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Cranioectodermal dysplasia (CED) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ce-dysp.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li><li class="half_rhythm"><div><i>De novo</i> pathogenic variants are only rarely reported [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>]. In such cases, one parent may not be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>. Thus, documentation of carrier status in both parents is appropriate.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li><li class="half_rhythm"><div>Rarely, as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> is likely no more than 1%-2% [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>]. However, it is difficult to assign a specific risk as it is unclear in whom the pathogenic variant arose (i.e., <i>de novo</i> mutation in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with CED in whom <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants have been identified in <i>IFT122</i>, <i>WDR35</i>, <i>IFT43</i>, or <i>WDR19</i> are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>Note: It is currently unclear whether individuals with CED are fertile as no individuals with CED have been reported to reproduce. This may be due to the severity of the disorder and to limited life span expectancy. Yet, CED may also be characterized by infertility as the genes that are mutated in this disorder encode proteins that are functional in cilia. These organelles are essential for sperm cell motility, and cilia in the Fallopian tube in turn sweep egg cells from the ovaries toward the uterus [<a class="bk_pop" href="#ce-dysp.REF.halbert.1976.1052">Halbert et al 1976</a>].</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>. (If one of the parents has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, the risk to the sibs of that individual is lower.)</p></div><div id="ce-dysp.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p></div><div id="ce-dysp.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#ce-dysp.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is prior to conception.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ce-dysp.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Fetal ultrasound examination.</b> Second-trimester ultrasound examination may detect renal cysts, shortening of the limbs, and/or polydactyly.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While decisions regarding prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ce-dysp.Resources"><h2 id="_ce-dysp_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Foundation for Ectodermal Dysplasias (NFED)</b></div><div>410 East Main Street</div><div>PO Box 114</div><div>Mascoutah IL 62258-0114</div><div><b>Phone:</b> 618-566-2020</div><div><b>Fax:</b> 618-566-4718</div><div><b>Email:</b> info@nfed.org</div><div><a href="http://www.nfed.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfed.org</a></div></li><li class="half_rhythm"><div><b>Ectodermal Dysplasias International Registry</b></div><div>National Foundation for Ectodermal Dysplasias</div><div>410 East Main Street</div><div>Mascoutah IL 62258</div><div><b>Phone:</b> 618-566-2020</div><div><b>Fax:</b> 618-566-4718</div><div><b>Email:</b> info@nfed.org</div><div><a href="https://nfed.patientcrossroads.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ectodermal Dysplasias International Registry</a></div></li></ul></div><div id="ce-dysp.Molecular_Genetics"><h2 id="_ce-dysp_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ce-dysp.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Cranioectodermal Dysplasia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ce-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ce-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ce-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ce-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ce-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ce-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/112752" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>IFT43</i></a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=112752" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96FT9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intraflagellar transport protein 43 homolog</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=IFT43" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFT43</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=IFT43[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFT43</a></td></tr><tr><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55764" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>IFT122</i></a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55764" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q21<wbr style="display:inline-block"></wbr>​.3-q22.1</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9HBG6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intraflagellar transport protein 122 homolog</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/IFT122" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFT122 database</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=IFT122" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFT122</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=IFT122[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IFT122</a></td></tr><tr><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57728" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>WDR19</i></a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57728" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4p14</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8NEZ3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WD repeat-containing protein 19</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/WDR19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR19 @ LOVD</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=WDR19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR19</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=WDR19[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR19</a></td></tr><tr><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57539" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>WDR35</i></a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57539" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p24<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9P2L0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WD repeat-containing protein 35</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=WDR35" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR35</a></td><td headers="hd_b_ce-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=WDR35[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WDR35</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ce-dysp.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ce-dysp.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Cranioectodermal Dysplasia (<a href="/omim/218330,606045,608151,613602,613610,614068,614099,614378" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/218330" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">218330</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CRANIOECTODERMAL DYSPLASIA 1; CED1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606045" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606045</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">INTRAFLAGELLAR TRANSPORT 122; IFT122</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608151" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608151</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WD REPEAT-CONTAINING PROTEIN 19; WDR19</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613602" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613602</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WD REPEAT-CONTAINING PROTEIN 35; WDR35</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613610" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613610</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CRANIOECTODERMAL DYSPLASIA 2; CED2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614068" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614068</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">INTRAFLAGELLAR TRANSPORT 43; IFT43</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614099" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614099</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CRANIOECTODERMAL DYSPLASIA 3; CED3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614378" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614378</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CRANIOECTODERMAL DYSPLASIA 4; CED4</td></tr></tbody></table></div></div><div id="ce-dysp.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Cranioectodermal dysplasia (CED) belongs to a spectrum of disorders known as "ciliopathies" [<a class="bk_pop" href="#ce-dysp.REF.baker.2009.281">Baker &#x00026; Beales 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2013.863">Arts &#x00026; Knoers 2013</a>]. Ciliopathies are thought to result from defects in cilia (<a class="figpopup" href="/books/NBK154653/figure/ce-dysp.F2/?report=objectonly" target="object" rid-figpopup="figcedyspF2" rid-ob="figobcedyspF2">Figure 2</a>), projections from the cell that occur almost ubiquitously throughout the human body. These microtubule-based organelles are thought to function as signaling hubs regulating pathways that are essential for normal human development and tissue homeostasis [<a class="bk_pop" href="#ce-dysp.REF.hildebrandt.2011.1533">Hildebrandt et al 2011</a>].</p><p>A process that is required for ciliogenesis and regulation of signaling pathways is ciliary transport (also known as intraflagellar transport [IFT]) [<a class="bk_pop" href="#ce-dysp.REF.hildebrandt.2011.1533">Hildebrandt et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.taschner.2012.s12">Taschner et al 2012</a>]. Upward (anterograde) movement of cargo or signaling molecules occurs through the multi-subunit IFT-B complex in association with the heterotrimeric kinesin-2 motor, while downward (i.e., tip-to-base [retrograde]) ciliary transport is regulated by the dynein-2 motor in association with the IFT-A complex [<a class="bk_pop" href="#ce-dysp.REF.hildebrandt.2011.1533">Hildebrandt et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.taschner.2012.s12">Taschner et al 2012</a>].</p><p>Remarkably, all pathogenic variants in individuals with CED identified to date occur in genes that encode members of the IFT-A hexamere protein complex: <i>IFT122</i> (previously <i>WDR10</i>), <i>WDR35</i> (<i>IFT121</i>), <i>WDR19</i> (<i>IFT144</i>), or <i>IFT43</i> (previously <i>C14orf179</i>) [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>, <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al 2013</a>]. The remaining two IFT-A complex members are <i>IFT139</i> and <i>IFT140</i>. Of note, genes encoding the proteins IFT139, IFT140, and DYNC2H1 (a subunit of dynein-2 motor) are mutated in disorders that clinically overlap with CED (see <a href="#ce-dysp.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#ce-dysp.REF.dagoneau.2009.706">Dagoneau et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.davis.2011.189">Davis et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.perrault.2012.864">Perrault et al 2012</a>].</p><p>When the IFT-A protein complex is disrupted in CED, cilia in fibroblasts have bulging tips, which contain accumulations of IFT-B complex proteins that normally regulate base-to-tip (anterograde) ciliary transport [<a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]. The functionality of intraflagellar transport in cilia from individuals with CED can be assessed by staining cells with anti-IFT-B antibodies.</p><p>Although shortening of cilia in fibroblasts from persons with CED has also been reported [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>], this is not always observed [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]. It is thought that defective IFT and resulting structural defects in the ciliary architecture disturb important developmental signaling cascades (e.g., hedgehog signaling), resulting in CED [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.ocbina.2011.547">Ocbina et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.qin.2011.1456">Qin et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.liem.2012.789">Liem et al 2012</a>].</p><div id="ce-dysp.IFT122_CED_1"><h4><i>IFT122</i> (CED 1)</h4><p><b>Gene structure.</b>
<i>IFT122</i> comprises 31 exons and is alternatively spliced in at least four variants. The largest transcript is <a href="/nuccore/NM_052985.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_052985</a>, encoding a 1,292-amino-acid product. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK154653/#ce-dysp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date six <i>IFT122</i> pathogenic variants (4 <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, a <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant, and a truncating variant) have been associated with CED [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.tsurusaki.2014.592">Tsurusaki et al 2014</a>]. The pathogenic variants are located in or close to WD40 domains. It has been suggested that pathogenic variants that give rise to CED do not completely abolish the function of IFT122 and, thus, the CED <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is relatively mild.</p><p>In contrast, the combination of a truncating variant (p.Glu370SerfsTer51) and a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (p.Gly546Arg), which was recently detected in a family with terminated pregnancies and recurrent pregnancy loss, appears to be more severe [<a class="bk_pop" href="#ce-dysp.REF.tsurusaki.2014.592">Tsurusaki et al 2014</a>].</p><div id="ce-dysp.T.ift122_pathogenic_variants_dis" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>IFT122</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.T.ift122_pathogenic_variants_dis/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.T.ift122_pathogenic_variants_dis_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.21G&#x0003e;C</td><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp7Cys</td><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_052985.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_052985<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_443711.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_443711<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.502+5G&#x0003e;A</td><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His143ValfsTer4&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1108delG</td><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu370SerfsTer51</td></tr><tr><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1118C&#x0003e;T</td><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser373Phe</td></tr><tr><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1636G&#x0003e;A</td><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly546Arg</td></tr><tr><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1658T&#x0003e;G</td><td headers="hd_h_ce-dysp.T.ift122_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val553Gly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ce-dysp.TF.3.1"><p class="no_margin">Proposed as an <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6 skip [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>]</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>IFT122</i> encodes intraflagellar transport 122 homolog, one of the six proteins of the intraflagellar transport A (IFT-A) protein complex [<a class="bk_pop" href="#ce-dysp.REF.piperno.1998.1591">Piperno et al 1998</a>, <a class="bk_pop" href="#ce-dysp.REF.taschner.2012.s12">Taschner et al 2012</a>]. This complex regulates retrograde transport in the cilium.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>IFT122</i> are thought to impair retrograde (tip-to-base) transport in the cilium. A study of cilia of fibroblasts from an individual with CED with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>IFT122</i> pathogenic variants revealed shortened cilia as compared to control cells [<a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>].</p><p>Similar structural defects have been identified in cilia from murine models (<i>sister of open brain</i>; <i>Ift122<sup>sopb</sup></i>, and a mutant that has defects in <i>Ift122</i> as well as in the overlapping <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>Med1</i>/<i>Mbd4</i>) and in a zebrafish model. Sonic hedgehog signaling defects have been observed in both models [<a class="bk_pop" href="#ce-dysp.REF.cortellino.2009.225">Cortellino et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.qin.2011.1456">Qin et al 2011</a>].</p></div><div id="ce-dysp.WDR35_CED_2"><h4><i>WDR35</i> (CED 2)</h4><p><b>Gene structure.</b>
<i>WDR35</i> comprises 28 exons. This <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is expressed in at least two WDR35 splice variants. The largest transcript (<a href="/nuccore/NM_001006657.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001006657.1</a>) encodes an 1,181-amino-acid protein. For a detailed summary of gene and protein information, see <a href="/books/NBK154653/#ce-dysp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of variants associated with CED have been identified in <i>WDR35</i>; i.e., six of the 11 families with CED with a molecular diagnosis had pathogenic variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.hoffer.2013.92">Hoffer et al 2013</a>].</p><p>The <i>WDR35</i> pathogenic variants include seven <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, one <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant, one stop variant, and a single-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, scattered throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#ce-dysp.REF.gilissen.2010.418">Gilissen et al 2010</a>, <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al 2012</a>].</p><div id="ce-dysp.T.wdr35_pathogenic_variants_disc" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>WDR35</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.T.wdr35_pathogenic_variants_disc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.T.wdr35_pathogenic_variants_disc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1877A&#x0003e;G</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu626Gly</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_3" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001006657.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001006657<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001006658.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001006658<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.25-2A&#x0003e;C</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile9ThrfsTer7</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2891del</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro964LeufsTer15</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3091C&#x0003e;T</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His1031Tyr</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3203A&#x0003e;G</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr1068Cys</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2623G&#x0003e;A</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala875Thr</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2912A&#x0003e;G</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr971Cys</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.504T&#x0003e;A</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser168Arg</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1922T&#x0003e;G</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu641Ter</td></tr><tr><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1592T&#x0003e;C</td><td headers="hd_h_ce-dysp.T.wdr35_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu531Pro&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ce-dysp.TF.4.1"><p class="no_margin">Reported by <a class="bk_pop" href="#ce-dysp.REF.bacino.2012.2917">Bacino et al [2012]</a> as p.Leu520Pro</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>WDR35</i> encodes one of the six members of IFT-A protein complex that regulates retrograde trafficking in the cilium [<a class="bk_pop" href="#ce-dysp.REF.piperno.1998.1591">Piperno et al 1998</a>, <a class="bk_pop" href="#ce-dysp.REF.taschner.2012.s12">Taschner et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Defects in WDR35 affect the process of intraflagellar transport. Immunocytochemistry revealed accumulations of IFT-B proteins (IFT57 and IFT88) in ciliary tips of cells derived from an individual with CED with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>WDR35</i> pathogenic variants [<a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>].</p><p>Such accumulations represent a typical "IFT-A" defect, and have previously been observed in ciliated cells of many different species, including <i>C. elegans</i>, <i>C. reinhardtii</i>, <i>D. melanogaster</i>, <i>T. brucei</i>, and <i>M. musculus,</i> wherein IFT-A orthologues were knocked out [<a class="bk_pop" href="#ce-dysp.REF.iomini.2001.13">Iomini et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.blacque.2006.5053">Blacque et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.absalon.2008.929">Absalon et al 2008</a>, <a class="bk_pop" href="#ce-dysp.REF.lee.2008.1899">Lee et al 2008</a>, <a class="bk_pop" href="#ce-dysp.REF.iomini.2009.885">Iomini et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.qin.2011.1456">Qin et al 2011</a>]. A <i>Wdr35</i> knockout mouse (<i>yeti</i>) was recently published. Homozygotes for a splice acceptor <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in a frameshift failed to form cilia, died during mid-gestation, and displayed a short rib-polydactyly <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#ce-dysp.REF.mill.2011.508">Mill et al 2011</a>] (see <a href="#ce-dysp.Genetically_Related_Allelic_Diso">Genetically Related Disorders</a>).</p></div><div id="ce-dysp.IFT43_CED_3"><h4><i>IFT43</i> (CED 3)</h4><p><b>Gene structure.</b> The longest <i>IFT43</i> transcript comprises eight exons. To date, three protein-encoding <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of <i>IFT43</i> are known. The largest transcript is <a href="/nuccore/NM_052873.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_052873</a>, which encodes a protein of 213 amino acids. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK154653/#ce-dysp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, <i>IFT43</i> pathogenic variants have only been reported in one family with CED, a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> family of Moroccan descent. The identified <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> variant (c.1A&#x0003e;G) is located in the translation initiation codon of <i>IFT43</i>, and is predicted to result in an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the first 21 amino acids of IFT43 [<a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>]. It has been suggested that the resulting IFT43 protein is still partly functional, and that the CED <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is most likely relatively mild [<a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>].</p><div id="ce-dysp.T.ift43_pathogenic_variants_disc" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>IFT43</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.T.ift43_pathogenic_variants_disc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.T.ift43_pathogenic_variants_disc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ce-dysp.T.ift43_pathogenic_variants_disc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ce-dysp.T.ift43_pathogenic_variants_disc_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ce-dysp.T.ift43_pathogenic_variants_disc_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ce-dysp.T.ift43_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1A&#x0003e;G</td><td headers="hd_h_ce-dysp.T.ift43_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met1_Lys21del&#x000a0;<sup>1</sup></td><td headers="hd_h_ce-dysp.T.ift43_pathogenic_variants_disc_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_052873.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_052873<wbr style="display:inline-block"></wbr>​.2 </a><br /><a href="/protein/NP_443105.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_443105<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ce-dysp.TF.5.1"><p class="no_margin">The nucleotide substitution in the ATG translation initiation codon results in initiation at next downstream ATG codon and an N-terminal <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 21 amino acids [<a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>IFT43</i> encodes the intraflagellar transport 43 homolog, a member of the IFT-A complex comprising six proteins [<a class="bk_pop" href="#ce-dysp.REF.taschner.2012.s12">Taschner et al 2012</a>].</p><p>Recent insights into the composition of the IFT-A protein complex in the unicellular alga <i>Chlamydomonas reinhardtii</i> revealed that the IFT-A proteins IFT43 and IFT121 (the ortholog of <i>WDR35</i>) directly interact [<a class="bk_pop" href="#ce-dysp.REF.behal.2012.11689">Behal et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> A study of ciliated fibroblasts of a person with CED with a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> translation initiation codon variant (c.1A&#x0003e;G) in <i>IFT43</i> revealed accumulations of IFT-B proteins (IFT88 and IFT57) in ciliary tips [<a class="bk_pop" href="#ce-dysp.REF.arts.2011.390">Arts et al 2011</a>]. This defect is consistent with a dysfunctional IFT-A protein complex [<a class="bk_pop" href="#ce-dysp.REF.iomini.2001.13">Iomini et al 2001</a>, <a class="bk_pop" href="#ce-dysp.REF.blacque.2006.5053">Blacque et al 2006</a>, <a class="bk_pop" href="#ce-dysp.REF.absalon.2008.929">Absalon et al 2008</a>, <a class="bk_pop" href="#ce-dysp.REF.lee.2008.1899">Lee et al 2008</a>, <a class="bk_pop" href="#ce-dysp.REF.iomini.2009.885">Iomini et al 2009</a>, <a class="bk_pop" href="#ce-dysp.REF.qin.2011.1456">Qin et al 2011</a>].</p></div><div id="ce-dysp.WDR19_CED_4"><h4><i>WDR19</i> (CED 4)</h4><p><b>Gene structure.</b>
<i>WDR19</i> comprises 37 exons, of which 36 are protein coding. A single <i>WDR19</i> transcript is known (<a href="/nuccore/NM_025132" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_025132</a>), which encodes a 1,342-amino-acid protein (<a href="/protein/NP_079408" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_079408</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK154653/#ce-dysp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, one family with CED and pathogenic variants in <i>WDR19</i> has been described. The two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs of this Norwegian family had <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> variants, including a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant and a stop variant [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>].</p><div id="ce-dysp.T.wdr19_pathogenic_variants_disc" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>WDR19</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK154653/table/ce-dysp.T.wdr19_pathogenic_variants_disc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ce-dysp.T.wdr19_pathogenic_variants_disc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2129T&#x0003e;C</td><td headers="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu710Ser</td><td headers="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_025132" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM<wbr style="display:inline-block"></wbr>​_025132</a><br /><a href="/protein/NP_079408" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP<wbr style="display:inline-block"></wbr>​_079408</a></td></tr><tr><td headers="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3307C&#x0003e;T</td><td headers="hd_h_ce-dysp.T.wdr19_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1103Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>WDR19</i> encoding intraflagellar transport protein 144 is one of the six subunits of the IFT-A protein complex [<a class="bk_pop" href="#ce-dysp.REF.piperno.1998.1591">Piperno et al 1998</a>, <a class="bk_pop" href="#ce-dysp.REF.taschner.2012.s12">Taschner et al 2012</a>] that regulates retrograde ciliary transport.</p><p>The discovery that WDR19 (IFT144) is associated with the IFT machinery was initially made <i>in Chlamydomonas reinhardtii</i> [<a class="bk_pop" href="#ce-dysp.REF.piperno.1998.1591">Piperno et al 1998</a>] and later in <i>Caenorhabditis elegans</i> [<a class="bk_pop" href="#ce-dysp.REF.efimenko.2006.4801">Efimenko et al 2006</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Fibroblasts from one of the Norwegian sibs with CED were studied; no WDR19/IFT144 protein was detectable in cilia from the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#ce-dysp.REF.bredrup.2011.634">Bredrup et al 2011</a>]. In addition, cilia were less abundant and shorter in the patient's cells compared to cilia from control cells. These findings indicate that IFT-A mediated transport is interrupted and can result in abnormal architecture of cilia.</p><p>Recently, two <i>Ift144</i> mouse models, one with a <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (<i>twinkle-toes</i>; <i>Ift144<sup>twt</sup></i> mutant) and the other with a severe <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> defect resulting in a truncated protein (<i>diamondhead</i>; <i>Ift144<sup>dmhd</sup></i> mutant), were reported [<a class="bk_pop" href="#ce-dysp.REF.ashe.2012.1808">Ashe et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.liem.2012.789">Liem et al 2012</a>]. Both mutants had skeletal features reminiscent of CED, although the <i>Ift144<sup>twt</sup></i> mutant could be analyzed in more detail than the <i>Ift144<sup>dmhd</sup></i> mutant as the latter already arrests development at embryonic stage E10.5 [<a class="bk_pop" href="#ce-dysp.REF.ashe.2012.1808">Ashe et al 2012</a>]. Subtle ciliary defects were reported in <i>Ift144<sup>twt</sup></i> mutants, while ciliogenesis appeared to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> in <i>Ift144<sup>dmhd</sup></i> mutants. This is consistent with the weak (hypomorphic) <i>Ift144<sup>twt</sup></i> variant and the more deleterious <i>Ift144<sup>dmhd</sup></i> variant [<a class="bk_pop" href="#ce-dysp.REF.ashe.2012.1808">Ashe et al 2012</a>, <a class="bk_pop" href="#ce-dysp.REF.liem.2012.789">Liem et al 2012</a>]. Different hedgehog defects have been described in the <i>Ift144<sup>dmhd</sup></i> and <i>Ift144<sup>twt</sup></i> mutants, i.e., ectopic activation of the hedgehog pathway versus decreased signaling, respectively [<a class="bk_pop" href="#ce-dysp.REF.liem.2012.789">Liem et al 2012</a>].</p></div></div></div><div id="ce-dysp.References"><h2 id="_ce-dysp_References_">References</h2><div id="ce-dysp.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.absalon.2008.929">Absalon S, Blisnick T, Kohl L, Toutirais G, Dor&#x000e9; G, Julkowska D, Tavenet A, Bastin P. Intraflagellar transport and functional analysis of genes required for flagellum formation in trypanosomes. <span><span class="ref-journal">Mol Biol Cell. </span>2008;<span class="ref-vol">19</span>:929–44.</span> [<a href="/pmc/articles/PMC2262991/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2262991</span></a>] [<a href="/pubmed/18094047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18094047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.adeva.2006.1">Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). <span><span class="ref-journal">Medicine (Baltimore). </span>2006;<span class="ref-vol">85</span>:1–21.</span> [<a href="/pubmed/16523049" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16523049</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.amar.1997.349">Amar MJ, Sutphen R, Kousseff BG. Expanded phenotype of cranioectodermal dysplasia (Sensenbrenner syndrome). <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">70</span>:349–52.</span> [<a href="/pubmed/9182772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9182772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.arts.2011.390">Arts HH, Bongers EM, Mans DA, van Beersum SE, Oud MM, Bolat E, Spruijt L, Cornelissen EA, Schuurs-Hoeijmakers JH, de Leeuw N, Cormier-Daire V, Brunner HG, Knoers NV, Roepman R. C14ORF179 encoding IFT43 is mutated in Sensenbrenner syndrome. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:390–5.</span> [<a href="/pubmed/21378380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21378380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.arts.2013.863">Arts HH, Knoers NV. Current insights into renal ciliopathies: what can genetics teach us? <span><span class="ref-journal">Pediatr Nephrol. </span>2013;<span class="ref-vol">28</span>:863–74.</span> [<a href="/pmc/articles/PMC3631122/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3631122</span></a>] [<a href="/pubmed/22829176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22829176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.ashe.2012.1808">Ashe A, Butterfield NC, Town L, Courtney AD, Cooper AN, Ferguson C, Barry R, Olsson F, Liem KF Jr, Parton RG, Wainwright BJ, Anderson KV, Whitelaw E, Wicking C. Mutations in mouse Ift144 model the craniofacial, limb and rib defects in skeletal ciliopathies. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:1808–23.</span> [<a href="/pmc/articles/PMC3313797/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3313797</span></a>] [<a href="/pubmed/22228095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22228095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.bacino.2012.2917">Bacino CA, Dhar SU, Brunetti-Pierri N, Lee B, Bonnen PE. WDR35 mutation in siblings with Sensenbrenner syndrome: a ciliopathy with variable phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:2917–24.</span> [<a href="/pmc/articles/PMC4000731/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4000731</span></a>] [<a href="/pubmed/22987818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22987818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.baker.2009.281">Baker K, Beales PL. Making sense of cilia in disease: the human ciliopathies. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2009;<span class="ref-vol">151C</span>:281–95.</span> [<a href="/pubmed/19876933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19876933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.baujat.2007.27">Baujat G, Le Merrer M. Ellis-van Creveld syndrome. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2007;<span class="ref-vol">2</span>:27.</span> [<a href="/pmc/articles/PMC1891277/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1891277</span></a>] [<a href="/pubmed/17547743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17547743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.beales.2007.727">Beales PL, Bland E, Tobin JL, Bacchelli C, Tuysuz B, Hill J, Rix S, Pearson CG, Kai M, Hartley J, Johnson C, Irving M, El&#x000e7;ioglu N, Winey M, Tada M, Scambler PJ. IFT80, which encodes a conserved intraflagellar transport protein, is mutated in Jeune asphyxiating thoracic dystrophy. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:727–9.</span> [<a href="/pubmed/17468754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17468754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.behal.2012.11689">Behal RH, Miller MS, Qin H, Lucker BF, Jones A, Cole DG. Subunit interactions and organization of the Chlamydomonas reinhardtii intraflagellar transport complex A proteins. <span><span class="ref-journal">J Biol Chem. </span>2012;<span class="ref-vol">287</span>:11689–703.</span> [<a href="/pmc/articles/PMC3320918/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3320918</span></a>] [<a href="/pubmed/22170070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22170070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.blacque.2006.5053">Blacque OE, Li C, Inglis PN, Esmail MA, Ou G, Mah AK, Baillie DL, Scholey JM, Leroux MR. The WD repeat-containing protein IFTA-1 is required for retrograde intraflagellar transport. <span><span class="ref-journal">Mol Biol Cell. </span>2006;<span class="ref-vol">17</span>:5053–62.</span> [<a href="/pmc/articles/PMC1679672/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1679672</span></a>] [<a href="/pubmed/17021254" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17021254</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.bredrup.2011.634">Bredrup C, Saunier S, Oud MM, Fiskerstrand T, Hoischen A, Brackman D, Leh SM, Midtb&#x000f8; M, Filhol E, Bole-Feysot C, Nitschk&#x000e9; P, Gilissen C, Haugen OH, Sanders JS, Stolte-Dijkstra I, Mans DA, Steenbergen EJ, Hamel BC, Matignon M, Pfundt R, Jeanpierre C, Boman H, R&#x000f8;dahl E, Veltman JA, Knappskog PM, Knoers NV, Roepman R, Arts HH. Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:634–43.</span> [<a href="/pmc/articles/PMC3213394/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3213394</span></a>] [<a href="/pubmed/22019273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22019273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.cortellino.2009.225">Cortellino S, Wang C, Wang B, Bassi MR, Caretti E, Champeval D, Calmont A, Jarnik M, Burch J, Zaret KS, Larue L, Bellacosa A. Defective ciliogenesis, embryonic lethality and severe impairment of the Sonic Hedgehog pathway caused by inactivation of the mouse complex A intraflagellar transport gene Ift122/Wdr10, partially overlapping with the DNA repair gene Med1/Mbd4. <span><span class="ref-journal">Dev Biol. </span>2009;<span class="ref-vol">325</span>:225–37.</span> [<a href="/pmc/articles/PMC2645042/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2645042</span></a>] [<a href="/pubmed/19000668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19000668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.coussa.2013.150">Coussa RG, Otto EA, Gee HY, Arthurs P, Ren H, Lopez I, Keser V, Fu Q, Faingold R, Khan A, Schwartzentruber J, Majewski J, Hildebrandt F, Koenekoop RK. WDR19: an ancient, retrograde, intraflagellar ciliary protein is mutated in autosomal recessive retinitis pigmentosa and in Senior-Loken syndrome. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">84</span>:150–9.</span> [<a href="/pmc/articles/PMC3904424/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3904424</span></a>] [<a href="/pubmed/23683095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23683095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.dagoneau.2009.706">Dagoneau N, Goulet M, Genevi&#x000e8;ve D, Sznajer Y, Martinovic J, Smithson S, Huber C, Baujat G, Flori E, Tecco L, Cavalcanti D, Delezoide AL, Serre V, Le Merrer M, Munnich A, Cormier-Daire V. DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">84</span>:706–11.</span> [<a href="/pmc/articles/PMC2681009/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2681009</span></a>] [<a href="/pubmed/19442771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19442771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.davis.2011.189">Davis EE, Zhang Q, Liu Q, Diplas BH, Davey LM, Hartley J, Stoetzel C, Szymanska K, Ramaswami G, Logan CV, Muzny DM, Young AC, Wheeler DA, Cruz P, Morgan M, Lewis LR, Cherukuri P, Maskeri B, Hansen NF, Mullikin JC, Blakesley RW, Bouffard GG. NISC Comparative Sequencing Program, Gyapay G, Rieger S, T&#x000f6;nshoff B, Kern I, Soliman NA, Neuhaus TJ, Swoboda KJ, Kayserili H, Gallagher TE, Lewis RA, Bergmann C, Otto EA, Saunier S, Scambler PJ, Beales PL, Gleeson JG, Maher ER, Atti&#x000e9;-Bitach T, Dollfus H, Johnson CA, Green ED, Gibbs RA, Hildebrandt F, Pierce EA, Katsanis N. TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:189–96.</span> [<a href="/pmc/articles/PMC3071301/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3071301</span></a>] [<a href="/pubmed/21258341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21258341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.efimenko.2006.4801">Efimenko E, Blacque OE, Ou G, Haycraft CJ, Yoder BK, Scholey JM, Leroux MR, Swoboda P. Caenorhabditis elegans DYF-2, an orthologue of human WDR19, is a component of the intraflagellar transport machinery in sensory cilia. <span><span class="ref-journal">Mol Biol Cell. </span>2006;<span class="ref-vol">17</span>:4801–11.</span> [<a href="/pmc/articles/PMC1635379/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1635379</span></a>] [<a href="/pubmed/16957054" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16957054</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.eke.1996.490">Eke T, Woodruff G, Young ID. A new oculorenal syndrome: retinal dystrophy and tubulointerstitial nephropathy in cranioectodermal dysplasia. <span><span class="ref-journal">Br J Ophthalmol. </span>1996;<span class="ref-vol">80</span>:490–1.</span> [<a href="/pmc/articles/PMC505510/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC505510</span></a>] [<a href="/pubmed/8695580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8695580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.el_hokayem.2012.227">El Hokayem J, Huber C, Couv&#x000e9; A, Aziza J, Baujat G, Bouvier R, Cavalcanti DP, Collins FA, Cordier MP, Delezoide AL, Gonzales M, Johnson D, Le Merrer M, Levy-Mozziconacci A, Loget P, Martin-Coignard D, Martinovic J, Mortier GR, Perez MJ, Roume J, Scarano G, Munnich A, Cormier-Daire V. NEK1 and DYNC2H1 are both involved in short rib polydactyly Majewski type but not in Beemer Langer cases. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:227–33.</span> [<a href="/pubmed/22499340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22499340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.el_ioglu.2002.392">El&#x000e7;ioglu NH, Hall CM. Diagnostic dilemmas in the short rib-polydactyly syndrome group. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">111</span>:392–400.</span> [<a href="/pubmed/12210298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12210298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.ellis.1940.65">Ellis RW, van Creveld S. A Syndrome Characterized by Ectodermal Dysplasia, Polydactyly, Chondro-Dysplasia and Congenital Morbus Cordis: Report of Three Cases. <span><span class="ref-journal">Arch Dis Child. </span>1940;<span class="ref-vol">15</span>:65–84.</span> [<a href="/pmc/articles/PMC1987729/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1987729</span></a>] [<a href="/pubmed/21032169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21032169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.estradacuzcano.2012.r111">Estrada-Cuzcano A, Roepman R, Cremers FP, den Hollander AI, Mans DA. Non-syndromic retinal ciliopathies: translating gene discovery into therapy. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:R111–24.</span> [<a href="/pubmed/22843501" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22843501</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.fry.2009.2212">Fry AE, Klingenberg C, Matthes J, Heimdal K, Hennekam RC, Pilz DT. Connective tissue involvement in two patients with features of cranioectodermal dysplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:2212–5.</span> [<a href="/pubmed/19760620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19760620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.gellis.1979.1275">Gellis S, Feingold M, Dubner D. Cranioectodermal dysplasia. <span><span class="ref-journal">Am J Dis Child. </span>1979;<span class="ref-vol">133</span>:1275–6.</span> [<a href="/pubmed/517478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 517478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.genitori.1992.601">Genitori L, Lang D, Philip N, Cavalheiro S, Lena G, Choux M. Cranioectodermal dysplasia with sagittal craniosynostosis (Sensenbrenner's syndrome): case report and review of the literature. <span><span class="ref-journal">Br J Neurosurg. </span>1992;<span class="ref-vol">6</span>:601–6.</span> [<a href="/pubmed/1472328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1472328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.gilissen.2010.418">Gilissen C, Arts HH, Hoischen A, Spruijt L, Mans DA, Arts P, van Lier B, Steehouwer M, van Reeuwijk J, Kant SG, Roepman R, Knoers NV, Veltman JA, Brunner HG. Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:418–23.</span> [<a href="/pmc/articles/PMC2933349/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2933349</span></a>] [<a href="/pubmed/20817137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20817137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.halbert.1976.1052">Halbert SA, Tam PY, Blandau RJ. Egg transport in the rabbit oviduct: the roles of cilia and muscle. <span><span class="ref-journal">Science. </span>1976;<span class="ref-vol">191</span>:1052–3.</span> [<a href="/pubmed/1251215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1251215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.halbritter.2013.865">Halbritter J, Porath JD, Diaz KA, Braun DA, Kohl S, Chaki M, Allen SJ, Soliman NA, Hildebrandt F, Otto EA., GPN Study Group.  Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathy. <span><span class="ref-journal">Hum Genet. </span>2013;<span class="ref-vol">132</span>:865–84.</span> [<a href="/pmc/articles/PMC4643834/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4643834</span></a>] [<a href="/pubmed/23559409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23559409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.hartong.2006.1795">Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. <span><span class="ref-journal">Lancet. </span>2006;<span class="ref-vol">368</span>:1795–809.</span> [<a href="/pubmed/17113430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17113430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.hildebrandt.2011.1533">Hildebrandt F, Benzing T, Katsanis N. Ciliopathies. <span><span class="ref-journal">N Engl J Med. </span>2011;<span class="ref-vol">364</span>:1533–43.</span> [<a href="/pmc/articles/PMC3640822/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3640822</span></a>] [<a href="/pubmed/21506742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21506742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.hoffer.2013.92">Hoffer JL, Fryssira H, Konstantinidou AE, Ropers HH, Tzschach A. Novel WDR35 mutations in patients with cranioectodermal dysplasia (Sensenbrenner syndrome). <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">83</span>:92–5.</span> [<a href="/pubmed/22486404" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22486404</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.huber.2012.165">Huber C, Cormier-Daire V. Ciliary disorder of the skeleton. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2012;<span class="ref-vol">160C</span>:165–74.</span> [<a href="/pubmed/22791528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22791528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.iomini.2001.13">Iomini C, Babaev-Khaimov V, Sassaroli M, Piperno G. Protein particles in Chlamydomonas flagella undergo a transport cycle consisting of four phases. <span><span class="ref-journal">J Cell Biol. </span>2001;<span class="ref-vol">153</span>:13–24.</span> [<a href="/pmc/articles/PMC2185522/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2185522</span></a>] [<a href="/pubmed/11285270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11285270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.iomini.2009.885">Iomini C, Li L, Esparza JM, Dutcher SK. Retrograde intraflagellar transport mutants identify complex A proteins with multiple genetic interactions in Chlamydomonas reinhardtii. <span><span class="ref-journal">Genetics. </span>2009;<span class="ref-vol">183</span>:885–96.</span> [<a href="/pmc/articles/PMC2778984/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2778984</span></a>] [<a href="/pubmed/19720863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19720863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.kjaer.2005.292">Kjaer KW, Hansen L, Schwabe GC, Marques-de-Faria AP, Eiberg H, Mundlos S, Tommerup N, Rosenberg T. Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome). <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:292–8.</span> [<a href="/pmc/articles/PMC1736041/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736041</span></a>] [<a href="/pubmed/15805154" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15805154</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.konstantinidou.2009.2206">Konstantinidou AE, Fryssira H, Sifakis S, Karadimas C, Kaminopetros P, Agrogiannis G, Velonis S, Nikkels PG, Patsouris E. Cranioectodermal dysplasia: a probable ciliopathy. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:2206–11.</span> [<a href="/pubmed/19760621" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19760621</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.lammer.1993.9">Lammer EJ, Baden H, Margolis RJ. Phenotype of cranioectodermal dysplasia with different hair and bone abnormalities. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">45</span>:9–13.</span> [<a href="/pubmed/8418667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8418667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.lang.1991.424">Lang GD, Young ID. Cranioectodermal dysplasia in sibs. <span><span class="ref-journal">J Med Genet. </span>1991;<span class="ref-vol">28</span>:424.</span> [<a href="/pmc/articles/PMC1016914/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016914</span></a>] [<a href="/pubmed/1870102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1870102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.lee.2008.1899">Lee E, Sivan-Loukianova E, Eberl DF, Kernan MJ. An IFT-A protein is required to delimit functionally distinct zones in mechanosensory cilia. <span><span class="ref-journal">Curr Biol. </span>2008;<span class="ref-vol">18</span>:1899–906.</span> [<a href="/pmc/articles/PMC2615538/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2615538</span></a>] [<a href="/pubmed/19097904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19097904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.levin.1977.55">Levin LS, Perrin JC, Ose L, Dorst JP, Miller JD, McKusick VA. A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: cranioectodermal dysplasia. <span><span class="ref-journal">J Pediatr. </span>1977;<span class="ref-vol">90</span>:55–61.</span> [<a href="/pubmed/830894" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 830894</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.liem.2012.789">Liem KF Jr, Ashe A, He M, Satir P, Moran J, Beier D, Wicking C, Anderson KV. The IFT-A complex regulates Shh signaling through cilia structure and membrane protein trafficking. <span><span class="ref-journal">J Cell Biol. </span>2012;<span class="ref-vol">197</span>:789–800.</span> [<a href="/pmc/articles/PMC3373400/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3373400</span></a>] [<a href="/pubmed/22689656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22689656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.lin.2013.2762">Lin AE, Traum AZ, Sahai I, Keppler-Noreuil K, Kukolich MK, Adam MP, Westra SJ, Arts HH. Sensenbrenner syndrome (cranioectodermal dysplasia): clinical and molecular analyses of 39 patients including two new patients. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2762–76.</span> [<a href="/pubmed/24123776" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24123776</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.mainzer.1970.556">Mainzer F, Saldino RM, Ozonoff MB, Minagi H. Familial nephropathy associated with retinitis pigmentosa, cerebellar ataxia and skeletal abnormalities. <span><span class="ref-journal">Am J Med. </span>1970;<span class="ref-vol">49</span>:556–62.</span> [<a href="/pubmed/4991086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4991086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.mill.2011.508">Mill P, Lockhart PJ, Fitzpatrick E, Mountford HS, Hall EA, Reijns MA, Keighren M, Bahlo M, Bromhead CJ, Budd P, Aftimos S, Delatycki MB, Savarirayan R, Jackson IJ, Amor DJ. Human and mouse mutations in WDR35 cause short-rib polydactyly syndromes due to abnormal ciliogenesis. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">88</span>:508–15.</span> [<a href="/pmc/articles/PMC3071922/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3071922</span></a>] [<a href="/pubmed/21473986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21473986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.oberklaid.1977.758">Oberklaid F, Danks DM, Mayne V, Campbell P. Asphyxiating thoracic dysplasia. Clinical, radiological, and pathological information on 10 patients. <span><span class="ref-journal">Arch Dis Child. </span>1977;<span class="ref-vol">52</span>:758–65.</span> [<a href="/pmc/articles/PMC1544803/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1544803</span></a>] [<a href="/pubmed/931421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 931421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.obikane.2006.574">Obikane K, Nakashima T, Watarai Y, Morita K, Cho K, Tonoki H, Nagata M, Sasaki S. Renal failure due to tubulointerstitial nephropathy in an infant with cranioectodermal dysplasia. <span><span class="ref-journal">Pediatr Nephrol. </span>2006;<span class="ref-vol">21</span>:574–6.</span> [<a href="/pubmed/16491415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16491415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.ocbina.2011.547">Ocbina PJ, Eggenschwiler JT, Moskowitz I, Anderson KV. Complex interactions between genes controlling trafficking in primary cilia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:547–53.</span> [<a href="/pmc/articles/PMC3132150/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3132150</span></a>] [<a href="/pubmed/21552265" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21552265</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.ohdo.1983.52">Ohdo S, Hirayama K, Terawaki T. Association of ectodermal dysplasia, ectrodactyly, and macular dystrophy: the EEM syndrome. <span><span class="ref-journal">J Med Genet. </span>1983;<span class="ref-vol">20</span>:52–7.</span> [<a href="/pmc/articles/PMC1048986/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1048986</span></a>] [<a href="/pubmed/6302256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6302256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.perrault.2012.864">Perrault I, Saunier S, Hanein S, Filhol E, Bizet AA, Collins F, Salih MA, Gerber S, Delphin N, Bigot K, Orssaud C, Silva E, Baudouin V, Oud MM, Shannon N, Le Merrer M, Roche O, Pietrement C, Goumid J, Baumann C, Bole-Feysot C, Nitschke P, Zahrate M, Beales P, Arts HH, Munnich A, Kaplan J, Antignac C, Cormier-Daire V, Rozet JM. Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutations. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:864–70.</span> [<a href="/pmc/articles/PMC3376548/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3376548</span></a>] [<a href="/pubmed/22503633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22503633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.piperno.1998.1591">Piperno G, Siuda E, Henderson S, Segil M, Vaananen H, Sassaroli M. Distinct mutants of retrograde intraflagellar transport (IFT) share similar morphological and molecular defects. <span><span class="ref-journal">J Cell Biol. </span>1998;<span class="ref-vol">143</span>:1591–601.</span> [<a href="/pmc/articles/PMC2132975/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2132975</span></a>] [<a href="/pubmed/9852153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9852153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.qin.2011.1456">Qin J, Lin Y, Norman RX, Ko HW, Eggenschwiler JT. Intraflagellar transport protein 122 antagonizes Sonic Hedgehog signaling and controls ciliary localization of pathway components. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:1456–61.</span> [<a href="/pmc/articles/PMC3029728/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3029728</span></a>] [<a href="/pubmed/21209331" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21209331</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.ruizperez.2000.283">Ruiz-Perez VL, Ide SE, Strom TM, Lorenz B, Wilson D, Woods K, King L, Francomano C, Freisinger P, Spranger S, Marino B, Dallapiccola B, Wright M, Meitinger T, Polymeropoulos MH, Goodship J. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">24</span>:283–6.</span> [<a href="/pubmed/10700184" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10700184</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.ruizperez.2003.728">Ruiz-Perez VL, Tompson SW, Blair HJ, Espinoza-Valdez C, Lapunzina P, Silva EO, Hamel B, Gibbs JL, Young ID, Wright MJ, Goodship JA. Mutations in two nonhomologous genes in a head-to-head configuration cause Ellis-van Creveld syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:728–32.</span> [<a href="/pmc/articles/PMC1180248/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180248</span></a>] [<a href="/pubmed/12571802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12571802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.savill.1997.215">Savill GA, Young ID, Cunningham RJ, Ansell I, Evans JH. Chronic tubulo-interstitial nephropathy in children with cranioectodermal dysplasia. <span><span class="ref-journal">Pediatr Nephrol. </span>1997;<span class="ref-vol">11</span>:215–7.</span> [<a href="/pubmed/9090669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9090669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.sensenbrenner.1975.372">Sensenbrenner JA, Dorst JP, Owens RP. New syndrome of skeletal, dental and hair anomalies. <span><span class="ref-journal">Birth Defects Orig Artic Ser. </span>1975;<span class="ref-vol">11</span>:372–9.</span> [<a href="/pubmed/1227553" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1227553</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.tamai.2002.78">Tamai S, Tojo M, Kamimaki T, Sato Y, Nishimura G. Intrafamilial phenotypic variations in cranioectodermal dysplasia: propositus with typical manifestations and her brother with perinatal death. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">107</span>:78–80.</span> [<a href="/pubmed/11807876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11807876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.taschner.2012.s12">Taschner M, Bhogaraju S, Lorentzen E. Architecture and function of IFT complex proteins in ciliogenesis. <span><span class="ref-journal">Differentiation. </span>2012;<span class="ref-vol">83</span>:S12–22.</span> [<a href="/pmc/articles/PMC3977345/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3977345</span></a>] [<a href="/pubmed/22118932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22118932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.tsurusaki.2014.592">Tsurusaki Y, Yonezawa R, Furuya M, Nishimura G, Pooh R, Nakashima M, Saitsu H, Miyake N, Saito S, Matsumoto N. Whole exome sequencing revealed biallelic IFT122 mutations in a family with CED1 and recurrent pregnancy loss. <span><span class="ref-journal">Clin Genet. </span>2014;<span class="ref-vol">85</span>:592–4.</span> [<a href="/pubmed/23826986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23826986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.walczaksztulpa.2010.949">Walczak-Sztulpa J, Eggenschwiler J, Osborn D, Brown DA, Emma F, Klingenberg C, Hennekam RC, Torre G, Garshasbi M, Tzschach A, Szczepanska M, Krawczynski M, Zachwieja J, Zwolinska D, Beales PL, Ropers HH, Latos-Bielenska A, Kuss AW. Cranioectodermal Dysplasia, Sensenbrenner syndrome, is a ciliopathy caused by mutations in the IFT122 gene. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:949–56.</span> [<a href="/pmc/articles/PMC3032067/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3032067</span></a>] [<a href="/pubmed/20493458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20493458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.wilson.2003.415">Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. <span><span class="ref-journal">J Pediatr. </span>2003;<span class="ref-vol">143</span>:415–21.</span> [<a href="/pubmed/14571209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14571209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.young.1989.393">Young ID. Cranioectodermal dysplasia (Sensenbrenner's syndrome). <span><span class="ref-journal">J Med Genet. </span>1989;<span class="ref-vol">26</span>:393–6.</span> [<a href="/pmc/articles/PMC1015626/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1015626</span></a>] [<a href="/pubmed/2661822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2661822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.zaffanello.2006.2336">Zaffanello M, Omedi-Camassei F, Melzi ML, Torre G, Callea F, Emma F. Sensenbrenner syndrome: a new member of the hepatorenal fibrocystic family. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:2336–40.</span> [<a href="/pubmed/17022080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17022080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ce-dysp.REF.zannolli.2001.332">Zannolli R, Mostardini R, Carpentieri ML, Gatti MG, Galluzzi P, Terrosi Vagnoli P, Giorgetti R, Calvieri S, Morgese G. Cranioectodermal dysplasia: a new patient with an inapparent, subtle phenotype. <span><span class="ref-journal">Pediatr Dermatol. </span>2001;<span class="ref-vol">18</span>:332–5.</span> [<a href="/pubmed/11576410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11576410</span></a>]</div></li></ul></div></div><div id="ce-dysp.Chapter_Notes"><h2 id="_ce-dysp_Chapter_Notes_">Chapter Notes</h2><div id="ce-dysp.Author_Notes"><h3>Author Notes</h3><p>This work was funded by the grants from the Dutch Kidney Foundation (CP11.18 "KOUNCIL" to N Knoers and H Arts) and the Netherlands Organization for Health Research and Development (ZonMw 91613008 to H. Arts); both projects aim to unravel the genetics and mechanisms of disease of renal ciliopathies including Sensenbrenner syndrome.</p></div><div id="ce-dysp.Acknowledgments"><h3>Acknowledgments</h3><p>We are thankful for the participation of the Sensenbrenner syndrome families in our study and for their consent for publication of clinical images. We also thank Dr E Lapi and Dr E Andreucci for their clinical contribution, Dr C Marcelis, Dr N van de Kar, Dr L Koster-Kamphuis and Dr K Noordam for useful discussions and Prof Dr HG Brunner for communication.</p></div><div id="ce-dysp.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>12 April 2018 (ha) Citation <a class="bk_pop" href="#ce-dysp.REF.lin.2013.2762">Lin et al [2013]</a> added</div></li><li class="half_rhythm"><div>12 September 2013 (me) Review posted live</div></li><li class="half_rhythm"><div>26 April 2012 (ha) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK154653</span><span class="label">PMID: <a href="/pubmed/24027799" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24027799</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/costello/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/m-hfm-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK154653&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK154653/?report=reader">PubReader</a></li><li><a href="/books/NBK154653/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK154653" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK154653" style="display:none" title="Cite this Page"><div class="bk_tt">Arts H, Knoers N. Cranioectodermal Dysplasia. 2013 Sep 12 [Updated 2018 Apr 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK154653/pdf/Bookshelf_NBK154653.pdf">PDF version of this page</a> (677K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ce-dysp.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ce-dysp.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ce-dysp.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ce-dysp.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ce-dysp.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ce-dysp.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ce-dysp.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ce-dysp.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ce-dysp.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ce-dysp.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ce-dysp.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=112752[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IFT43</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57539[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">WDR35</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57728[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">WDR19</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55764[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IFT122</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK154653+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3052252" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3052252" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3052252" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3052252" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29134781" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and molecular genetic characterization of a male patient with Sensenbrenner syndrome (cranioectodermal dysplasia) and biallelic WDR35 mutations.</a><span class="source">[Birth Defects Res. 2018]</span><div class="brieflinkpop offscreen_noflow">Clinical and molecular genetic characterization of a male patient with Sensenbrenner syndrome (cranioectodermal dysplasia) and biallelic WDR35 mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Walczak-Sztulpa J, Wawrocka A, Swiader-Lesniak A, Socha M, Jamsheer A, Drozdz D, Latos-Bielenska A, Zachwieja K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Birth Defects Res. 2018 Mar 1; 110(4):376-381. Epub 2017 Nov 14.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28332779" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Intrafamilial phenotypic variability in a Polish family with Sensenbrenner syndrome and biallelic WDR35 mutations.</a><span class="source">[Am J Med Genet A. 2017]</span><div class="brieflinkpop offscreen_noflow">Intrafamilial phenotypic variability in a Polish family with Sensenbrenner syndrome and biallelic WDR35 mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Walczak-Sztulpa J, Wawrocka A, Sobierajewicz A, Kuszel L, Zawadzki J, Grenda R, Swiader-Lesniak A, Kocyla-Karczmarewicz B, Wnuk A, Latos-Bielenska A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2017 May; 173(5):1364-1368. Epub 2017 Mar 23.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27336129" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nephronophthisis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nephronophthisis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stokman M, Lilien M, Knoers N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301500" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Joubert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Joubert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Parisi M, Glass I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301537" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Bardet-Biedl Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Bardet-Biedl Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Forsythe E, Beales PL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24027799" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24027799" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8c4e39a66ee2ba3cb763">Cranioectodermal Dysplasia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Cranioectodermal Dysplasia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T03:54:38-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AB31CDFC84B310000000003A501D0&amp;ncbi_session=CE8AB31CDFC8C4E1_0933SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK154653%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK154653&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK154653/&amp;ncbi_pagename=Cranioectodermal Dysplasia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AB31CDFC8C4E1_0933SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>